In terms of the genotypic frequencies of the Il-1β gene polymorphisms (as illustrated in Table S3 and in accordance with the other population data), there is no association between the Il-1β promoter polymorphism and the risk of BC. The gene discussed is IL1B; the disease is breast cancer.